The invention relates to compounds of formula (I) wherein R1 represents optionally substituted amino, optionally substituted phenyl, optionally substituted heteroaryl, optionally substituted heterocyclyl, optionally substituted phenyl- or heteroaryl-alkyl, optionally substituted phenylaminocarbonyl-alkoxyalkyl or an alkenyl group as defined in the specification. These compounds are useful for the treatment of hyperproliferative diseases, in particular, liver cancers.
该发明涉及式(I)的化合物,其中R1代表根据规范中定义的可选择取代的
氨基、可选择取代的苯基、可选择取代的杂环芳基、可选择取代的杂环烷基、可选择取代的苯基或杂环芳基烷基、可选择取代的苯基
氨基羰基-烷氧基烷或烯基基团。这些化合物可用于治疗高增殖性疾病,特别是肝癌。